| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC8160 | ZGN-440(Beloranib) | Beloranib is being studied as a first-in-class obesity therapy that demonstrates a unique mechanism of action through methionine aminopeptidase 2 (MetAP2 ) inhibition. |
|
| DC9414 | DGAT-1 inhibitor 2 | DGAT-1 inhibitor 2 is an effective inhibitor of DGAT-1;antiobesity agents. |
|
| DC12255 | MLN-4760 Featured | MLN-4760 is a potent and selective human ACE2 inhibitor (IC50, 0.44 nM), with excellent selectivity (>5000-fold) versus related enzymes including human testicular ACE (IC50, >100 μM) and bovine carboxypeptidase A (CPDA; IC50, 27 μM). |
|
| DC7109 | Otenabant (CP-945598 free base) Featured | Otenabant (CP945598) is a recently discovered selective, high affinity, competitive CB1 receptor antagonist with Ki of 0.7 nM. |
|
| DC7495 | SB-334867 HCl Featured | SB-334867 is a selective non-peptide orexin OX1 receptor antagonist with a pKb value of 7.2. |
|
| DC8419 | SB-334867 Featured | SB-334867 is a selective orexin-1 (OX1) receptor antagonist. |
|
| DC4158 | Tranabant (MK-0364) | Taranabant is a highly selective cannabinoid-1 (CB1) receptor inverse agonist. |
|
| DC1076 | Otenabant(CP945598.HCl) Featured | CP-945598 HCl is a potent and selective cannabinoid type 1 receptor antagonist with Ki of 0.7 nM. |
|
